NITRILE EXAM GLOVES, LRG. N8803I

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2003-04-18 for NITRILE EXAM GLOVES, LRG. N8803I manufactured by Cardinal Health.

Event Text Entries

[17802094] Dr. States after wearing the glove they experienced skin irritation and itching which required using otc hydrocortisone cream and prescriptive fluocinonlde cream 0. 05%.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1423507-2003-00052
MDR Report Key454569
Report Source04
Date Received2003-04-18
Date of Report2003-04-18
Date Mfgr Received2003-03-21
Date Added to Maude2003-04-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactPATRICIA SHARPE-GREGG
Manufacturer Street1430 WAUKEGAN ROAD
Manufacturer CityMCGAW PARK IL 60085
Manufacturer CountryUS
Manufacturer Postal60085
Manufacturer Phone8475784148
Manufacturer G1*
Manufacturer StreetPLOT 87 KAMPUNG JAWA
Manufacturer CityPENANG W.
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNITRILE EXAM GLOVES, LRG.
Generic NameEXAM GLOVES
Product CodeLZC
Date Received2003-04-18
Returned To Mfg2003-04-11
Model NumberN8803I
Catalog NumberN8803I
Lot Number3H03A533
ID NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by Mfgr*
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key443572
ManufacturerCARDINAL HEALTH
Manufacturer Address1500 WAUKEGAN ROAD MCGAW PARK IL 60085 US
Baseline Brand NameNITRILE EXAM GLOVES, LRG
Baseline Generic NameEXAM GLOVES
Baseline Model NoN8803I
Baseline Catalog NoN8803I
Baseline IDNA
Baseline Device FamilyGLOVES
Baseline Shelf Life ContainedN
Baseline Shelf Life [Months]60
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK000813
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2003-04-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.